Jorge J. Castillo, MD, discusses preliminary data from a phase 2 study of acalabrutinib plus rituximab in patients with IgM symptomatic anti-MAG peripheral neuropathy.
Jorge J. Castillo, MD, discusses the ongoing investigation into potential treatment options for patients with Waldenström macroglobulinemia, including iopofosine I-131.
Melinda Buntin, Bloomberg Distinguished Professor of Health Policy and Economics, will lead a newly established Center for Health Systems and Policy Modeling